Lilly Sees Approval Soon for Long-Acting Zyprexa From Reuters Health - May 29, 2008 NEW YORK (Reuters) - Eli Lilly and Co said on Thursday a long-acting form of its schizophrenia drug Zyprexa will likely become available in the United States in the "near future," based on favorable signals from U.S. regulators. Chief Executive John Lechleiter said Lilly's optimism is based on recent meetings between the company and the FDA, which in February had rejected the injectable form of Lilly's biggest-selling medicine. www.peoplewho.org